Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogens comprising human immunodeficiency virus V1/V2 polypeptides

Immunogens comprising human immunodeficiency virus V1/V2 polypeptides

US Patent 9988424 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-varicella-zoster virus antibody2025
Inhibitors of complement factor H2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
HIV-1 envelope stabilizing mutations2024
HIV-1 neutralizing antibodies and uses thereof2024
Methods of inhibiting complement factor H (CFH) comprising administering an anti2024
Compositions comprising HIV envelopes to induce CH235 lineage antibodies2024
Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika 2024
Compositions comprising modified HIV envelopes2023
Mosaic HIV-1 envelopes to induce ADCC responses2023
Methods to identify immunogens by targeting improbable mutations2023
Human neutralizing anti-tetanus toxin monoclonal antibody and its applications2023